Inventor · disambiguated record
Giancarlo Santus
Also filed as: SANTUS GIANCARLO
28 granted patents·9 pending applications·3,158 citations·filing 1991–2018
98Inventor score
Top patents by PatentIndex Score
37 records- 0196US10772854B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2018·Granted Sep 15, 2020·6 cites·72 claims
- 0295US5674533APharmaceutical composition for the controlled release of moguisteine in a liquid suspensionRECORDATI CHEM PHARM·Filed 1995·Granted Oct 7, 1997·1.6k cites·34 claims
- 0395US5593684AMethod and therapeutic system for smoking cessationPHARMACIA AB·Filed 1994·Granted Jan 14, 1997·174 cites·14 claims
- 0495US5362496AMethod and therapeutic system for smoking cessationPHARMACIA AB·Filed 1993·Granted Nov 8, 1994·164 cites·12 claims
- 0594US10292951B2Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2016·Granted May 21, 2019·9 cites·60 claims
- 0694US5472704APharmaceutical controlled-release composition with bioadhesive propertiesRECORDATI CHEM PHARM·Filed 1993·Granted Dec 5, 1995·259 cites·23 claims
- 0792US5721257AMethod and therapeutic system for smoking cessationPHARMACIA & UPJOHN AB·Filed 1995·Granted Feb 24, 1998·112 cites·5 claims
- 0891US6214386B1Prompt-release oral pharmaceutical compositions for extemporaneous suspensionsRECORDATI CHEM PHARM·Filed 1996·Granted Apr 10, 2001·123 cites·34 claims
- 0990US5952021AStabilized biologically active compounds contained in coated microgranules which can be suspended in alimentary fluidsRECORDATI CHEM PHARM·Filed 1997·Granted Sep 14, 1999·70 cites·16 claims
- 1089US7476689B2Therapeutic compositions for intranasal administration which include KETOROLACRECORDATI IRELAND LTD·Filed 2004·Granted Jan 13, 2009·23 cites·22 claims
- 1186US5571533AControlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemideRECORDATI CHEM PHARM·Filed 1994·Granted Nov 5, 1996·111 cites·27 claims
- 1285US6333044B1Therapeutic compositions for intranasal administration which include KETOROLAC®RECORDATI CHEM PHARM·Filed 1995·Granted Dec 25, 2001·53 cites·51 claims
- 1384US5527545ALiquid-suspension controlled-release pharmaceutical compositionRECORDATI CHEM PHARM·Filed 1993·Granted Jun 18, 1996·66 cites·10 claims
- 1483US5503843ATransdermal delivery of alpha adrenoceptor blocking agentsFLORA INC·Filed 1994·Granted Apr 2, 1996·72 cites·20 claims
- 1583US5460828AProcess for the preparation of microgranules suitable for suspension in fluidsRECORDATI CHEM PHARM·Filed 1994·Granted Oct 24, 1995·74 cites·13 claims
- 1681US5296236AControlled release therapeutic system for a liquid pharmaceutical formulationsRECORDATI CHEM PHARM·Filed 1992·Granted Mar 22, 1994·53 cites·20 claims
- 1779US7199258B2Process for preparing nitrooxyderivatives of naproxenNICOX SA·Filed 2003·Granted Apr 3, 2007·7 cites·9 claims
- 1873US5658587ATransdermal delivery of alpha adrenoceptor blocking agentsFLORA INC·Filed 1995·Granted Aug 19, 1997·42 cites·26 claims
- 1972US7267827B2Therapeutic compositions for intranasal administration which include KETOROLACRECORDATI CHEM PHARM·Filed 2001·Granted Sep 11, 2007·2 cites·12 claims
- 2069US7166605B2Probucol nitro-derivativesNICOX SA·Filed 2003·Granted Jan 23, 2007·4 cites·28 claims
- 2169US5670171ALiquid-suspension controlled-release pharmaceutical compositionRECORDATI CHEM PHARM·Filed 1995·Granted Sep 23, 1997·30 cites·3 claims
- 2268US7776902B2Nitrooxyderivatives of cyclooxygenase-2 inhibitorsNICOX SA·Filed 2003·Granted Aug 17, 2010·3 cites·13 claims
- 2368US7723382B2Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereofNICOX SA·Filed 2003·Granted May 25, 2010·3 cites·12 claims
- 2467US5510119AControlled release therapeutic system for liquid pharmaceutical formulationsRECORDATI CHEM PHARM·Filed 1995·Granted Apr 23, 1996·25 cites·3 claims
- 2556US2010217028A1Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereofNICOX SA·Filed 2010·Application pending·0 cites
- 2652US10086002B2Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagusEMS SA·Filed 2017·Granted Oct 2, 2018·0 cites·2 claims
- 2752US5405619AControlled release therapeutic system for liquid pharmaceutical formulationsRECORDATI CHEM PHARM·Filed 1994·Granted Apr 11, 1995·13 cites·2 claims
- 2850US2018235979A1Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagusEMS SA·Filed 2018·Application pending·0 cites
- 2948US2010168216A1Prostaglandin pharmaceutical compositionsCTG PHARMA S R L·Filed 2008·Application pending·0 cites
- 3048US2013273114A1Pharmaceutical compositions of immunosuppressantsSANTUS GIANCARLO·Filed 2012·Application pending·0 cites
- 3147US9980975B2Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagusEMS SA·Filed 2015·Granted May 29, 2018·0 cites·1 claims
- 3247US2006171969A1Oral pharmaceutical forms of liquid drugs having improved bioavailabilityMACELLONI CRISTINA·Filed 2003·Application pending·0 cites
- 3345US2009017003A1Thiosulfonate anti-inflammatory agentsSULFIDRIS S R L·Filed 2007·Application pending·0 cites
- 3444US5165937AControlled release tablets containing flavoxateRECORDATI CHEM PHARM·Filed 1991·Granted Nov 24, 1992·11 cites·9 claims
- 3535US2018362456A1New compounds with antioxidant and antiaging activityEMS S/A·Filed 2016·Application pending·0 cites
- 3634US2015110885A1Parenteral pharmaceutical composition containing cosyntropinEMS SA·Filed 2014·Application pending·0 cites
- 3732US2014314848A1Pharmaceutical compositions of antihypertensivesEMS SA·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Giancarlo Santus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →